Journal of Antimicrobial Chemotherapy, Vol 40, 205-211, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
MA Cohen, MD Huband, JW Gage, SL Yoder, GE Roland and SJ Gracheck
Clinafloxacin and trovafloxacin are two new fluoroquinolones for which few
comparative data are available. When MICs of ciprofloxacin against
Gram-positive and Gram-negative nosocomial species were compared,
clinafloxacin was the most potent although trovafloxacin was also more
active than ciprofloxacin against Staphylococcus aureus and enterococci.
All three drugs were bactericidal. Clinafloxacin displayed the lowest
frequency of resistance, approximating 10(-11). Development of resistance
studies over 13-14 passages in the presence of drug revealed a 32-fold
increase in MIC of clinafloxacin against S. aureus compared with 512- and
1024-fold for trovafloxacin and ciprofloxacin respectively, although the
three drugs were comparable against Enterococcus faecalis and the
Gram-negative bacilli.
ORIGINAL ARTICLES
In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin
Therapeutics Department, Parke-Davis Pharmaceutical Research, Division of Warner Lambert Company, Ann Arbor, MI 48105-2495, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. J. Randinitis, J. I. Brodfuehrer, I. Eiseman, and A. B. Vassos Pharmacokinetics of Clinafloxacin after Single and Multiple Doses Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2529 - 2535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Randinitis, J. R. Koup, G. Rausch, R. Abel, N. J. Bron, N. J. Hounslow, A. B. Vassos, and A. J. Sedman Clinafloxacin Pharmacokinetics in Subjects with Various Degrees of Renal Function Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2536 - 2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Randinitis, C. W. Alvey, J. R. Koup, G. Rausch, R. Abel, N. J. Bron, N. J. Hounslow, A. B. Vassos, and A. J. Sedman Drug Interactions with Clinafloxacin Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2543 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oh, N. El Amin, T. Davies, P. C. Appelbaum, and C. Edlund gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains Antimicrob. Agents Chemother., July 1, 2001; 45(7): 1977 - 1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Siami, N. Christou, I. Eiseman, K. J. Tack, and the Clinafloxacin Severe Skin And Soft Tissue Infe Clinafloxacin versus Piperacillin-Tazobactam in Treatment of Patients with Severe Skin and Soft Tissue Infections Antimicrob. Agents Chemother., February 1, 2001; 45(2): 525 - 531. [Abstract] [Full Text] |
||||
![]() |
E. S. R. Darley, A. P. MacGowan, R. A. Howe, and C. M. Tobin Clinafloxacin serum concentrations in a patient on continuous veno-venous haemofiltration J. Antimicrob. Chemother., June 1, 2000; 45(6): 927 - 928. [Full Text] [PDF] |
||||
![]() |
D. R. Snydman, N. V. Jacobus, L. A. McDermott, and S. E. Supran Comparative In Vitro Activities of Clinafloxacin and Trovafloxacin against 1,000 Isolates of Bacteroides fragilis Group: Effect of the Medium on Test Results Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1710 - 1712. [Abstract] [Full Text] |
||||
![]() |
D. Milatovic, F.-J. Schmitz, S. Brisse, J. Verhoef, and A. C. Fluit In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates Antimicrob. Agents Chemother., April 1, 2000; 44(4): 1102 - 1107. [Abstract] [Full Text] |
||||
![]() |
C. L. Clark, M. R. Jacobs, and P. C. Appelbaum Activities of Clinafloxacin, Alone and in Combination with Other Compounds, against 45 Gram-Positive and -Negative Organisms for Which Clinafloxacin MICs Are High Antimicrob. Agents Chemother., September 1, 1999; 43(9): 2295 - 2298. [Abstract] [Full Text] |
||||
![]() |
C. D. Steward, S. A. Stocker, J. M. Swenson, C. M. O'Hara, J. R. Edwards, R. P. Gaynes, J. E. McGowan Jr., and F. C. Tenover Comparison of Agar Dilution, Disk Diffusion, MicroScan, and Vitek Antimicrobial Susceptibility Testing Methods to Broth Microdilution for Detection of Fluoroquinolone-Resistant Isolates of the Family Enterobacteriaceae J. Clin. Microbiol., March 1, 1999; 37(3): 544 - 547. [Abstract] [Full Text] |
||||
![]() |
L. J. V. Piddock, M. Johnson, V. Ricci, and S. L. Hill Activities of New Fluoroquinolones against Fluoroquinolone-Resistant Pathogens of the Lower Respiratory Tract Antimicrob. Agents Chemother., November 1, 1998; 42(11): 2956 - 2960. [Abstract] [Full Text] |
||||
![]() |
L. M. Ednie, M. R. Jacobs, and P. C. Appelbaum Comparative Activities of Clinafloxacin against Gram-Positive and -Negative Bacteria Antimicrob. Agents Chemother., May 1, 1998; 42(5): 1269 - 1273. [Abstract] [Full Text] |
||||


